, ,

Lp(a) test: what lipoprotein(a) is and who should have it measured once

Schematic of a lipoprotein(a) particle: yellow LDL particle with an attached blue apo(a) chain

Many people know their cholesterol, hardly anyone knows their Lp(a). Yet about one in five people has a raised lipoprotein(a) level, usually without knowing it. The value is largely inherited and increases the risk of heart attack and stroke. European guidelines therefore recommend measuring it once in a lifetime.

In short: Lp(a) is a blood fat particle whose level is more than 90 per cent determined by your genes. A value above 50 mg/dL is considered clearly raised. Once measured, it hardly changes. There is not yet a medicine that specifically lowers Lp(a) and thereby prevents heart attacks – the large Lp(a)HORIZON trial missed its goal in November 2026. People with a high value still benefit from having all other risk factors particularly well controlled.

What is Lp(a)?

Lipoprotein(a), Lp(a) for short, is a particle that transports fats in the blood. It resembles the well-known LDL cholesterol but also carries a large protein, apolipoprotein(a). This protein makes the particle particularly “sticky”: Lp(a) is deposited more easily in vessel walls, promotes inflammation and can favour blood clots. High levels are therefore linked to a higher risk of heart attack, stroke, poor circulation in the legs and narrowing of the aortic valve. For background, see our encyclopedia entries on cholesterol and atherosclerosis.

Why do so few people know their level?

Lp(a) is not part of the standard cholesterol check at the GP. It causes no symptoms and cannot be read from normal cholesterol values: even people with good LDL cholesterol, a healthy weight and a healthy lifestyle can have high Lp(a). The reason is that the level is more than 90 per cent determined by genes. A high value can therefore explain why heart attacks or strokes occur at a young age in some families.

Which values count as raised?

  • Below 30 mg/dL (roughly below 75 nmol/L): unremarkable
  • 30 to 50 mg/dL (roughly 75 to 105 nmol/L): grey zone
  • Above 50 mg/dL (roughly above 105 nmol/L): clearly raised, cardiovascular risk increases

Laboratories report Lp(a) either in mg/dL or in nmol/L. The two units cannot be converted exactly because Lp(a) particles differ in size depending on your genes. Always read values together with the unit and the reference limits of the laboratory. According to the European guideline, a clearly raised value can move someone at moderate risk into the high-risk group – and then, for example, stricter LDL cholesterol targets apply.

Who should have Lp(a) measured?

The joint guideline of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) recommends in its 2025 update that Lp(a) be measured at least once in every adult’s lifetime. Testing is particularly useful

  • if parents or siblings had a heart attack or stroke at a young age,
  • if you already have cardiovascular disease yourself, especially without a clear cause,
  • if raised Lp(a) is known in your family,
  • if your cholesterol falls poorly despite treatment.

Who pays for the test in Germany?

Statutory health insurance covers the cost if there is a medical reason, such as known cardiovascular disease or early heart attacks in the family. Without such a reason, the test is a self-pay service; according to a large laboratory network, the price under the German fee schedule is around 20 euros. Ask your practice – it is a simple blood test.

What to do if your level is high

Diet or exercise cannot lower Lp(a) to any meaningful degree. Still, a lot can be done: people with a high value should tackle their other risk factors all the more consistently. These include well-controlled LDL cholesterol, normal blood pressure, good blood sugar, stopping smoking and regular exercise. How much deposits in the coronary arteries can shrink with good cholesterol lowering is shown in our article Rosuvastatin plus ezetimibe: intensive cholesterol lowering shrinks coronary plaque. Background on statins: Statins.

For people with very high Lp(a) and progressing cardiovascular disease despite the best treatment, a blood-cleaning procedure (lipoprotein apheresis) is available in Germany under strict conditions. The directive of the Federal Joint Committee names, among other things, an isolated Lp(a) above 60 mg/dL with normal LDL cholesterol and a clinically and radiologically documented worsening of vascular disease. Specialised centres decide whether this is an option.

New medicines: what does Lp(a)HORIZON show?

Lp(a) has long been seen as a promising target for new medicines. In November 2026, the results of the large Lp(a)HORIZON trial were published in the New England Journal of Medicine. 8,322 people with known cardiovascular disease and Lp(a) of at least 70 mg/dL received the drug pelacarsen or placebo for almost five years. Pelacarsen lowered Lp(a) by around 78 per cent – but major cardiovascular events occurred equally often in both groups (12.3 versus 12.1 per cent). The manufacturer has since stopped the programme.

Why the drug did not work is unclear. Experts suggest, among other things, that vascular disease in the participants was already too advanced or that their other risk factors were already very well treated. Other Lp(a)-lowering drugs such as olpasiran, lepodisiran and muvalaplin are being tested in large trials. Whether lowering Lp(a) prevents heart attacks therefore remains unproven. More in our weekly review for week 46.

Frequently asked questions

What is a normal Lp(a) level?

Values below 30 mg/dL (roughly below 75 nmol/L) are considered unremarkable. From 50 mg/dL (roughly 105 nmol/L), the level is clearly raised. Check the unit and the reference limits of your laboratory.

Can diet lower Lp(a)?

Hardly. The level is mainly determined by genes. A healthy lifestyle is still important because it lowers the other risk factors for the heart and blood vessels.

How often should Lp(a) be measured?

One measurement in a lifetime is usually enough, because the level remains largely stable. Repeat testing can make sense in special situations, for example with kidney disease.

Is there a medicine for high Lp(a)?

Not yet. The drug pelacarsen lowered Lp(a) strongly but did not prevent cardiovascular events in the Lp(a)HORIZON trial. Further drugs are being tested.

Note: This article is for general information only and does not replace medical advice. Status: November 2026.

Sources

AnzeigeAnzeige: WUNDREPAIR – Pflege aus Pflanzen

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.